ライフサイエンスコーパス: translocator

1 esumed to somehow serve as both receptor and translocator.

2 red N-terminal translocation domain into the translocator.

3 ir it recruits another Cir protein as its OM translocator.

4 but not on aryl hydrocarbon receptor nuclear translocator.

5 assenger domain and a 30-kDa-long C-terminal translocator.

6 , a small ATPase proposed to be part of this translocator.

7 athway and requires the HMW1B outer membrane translocator.

8 nstitution and analysis of membrane-inserted translocators.

9 sion mRNA was expressed in B-cell-restricted translocators.

10 membrane by secreting two proteins known as translocators.

11 I (COI)] or nuclear DNA [adenine nucleotide translocator 1 (ANT1) and nicotinamide nucleotide transh

12 art and muscle isoform of adenine nucleotide translocator 1 (ANT1) are associated with autosomal-domi

13 , cardiac troponin-I, and adenine nucleotide translocator 1 (ANT1), have been identified as autoantig

14 we identified Plastidal glycolate glycerate translocator 1 (PLGG1) as a candidate core photorespirat

15 Ten homozygous null (adenine nucleotide translocator-1(-/-)) patients monitored over a median of

16 art-muscle isoform of the adenine nucleotide translocator-1.

17 nce fimbriae (AAF), dispersin, the dispersin translocator Aat, and the Aai type VI secretion system,

18 f the beta-barrel pore, and the mechanism of translocator activity.

19 Infection enhanced AHR/AHR nuclear translocator and AHR/RELB DNA binding and stimulated the

20 the possibility that it functions as both a translocator and an effector.

21 hibit translation elongation also jammed the translocator and caused the degradation of translocator

22 ulatory elements, such as adenine nucleotide translocator and cyclophilin D (possibly voltage-depende

23 a type III secretion system (T3SS) to export translocator and effector proteins required for mucosal

24 ecretion of type III secretion system (T3SS) translocator and effector proteins.

25 h degradation involve the adenine nucleotide translocator and mitochondrial permeability transition p

26 rizes with aryl hydrocarbon receptor nuclear translocator and modulates gene transcription.

27 e AHR and heterodimeric partners AHR nuclear translocator and RELB are robustly expressed, and AHR an

28 th mitochondrial proteins adenine nucleotide translocator and voltage-dependent anion channel, result

29 Basal expression of AhR, the AhR nuclear translocator, and the CYP1 family members do not predict

30 ot its dimerization partner, the AHR nuclear translocator, and the repressive effects of TIPARP on AH

31 We have identified the adenine nucleotide translocator (ANT) isoforms ANT1 and ANT2 that are prese

32 (3-) via the electrogenic adenine nucleotide translocator (ANT) located in the mitochondrial inner me

33 ent anion channel (VDAC), adenine nucleotide translocator (ANT), and cyclophilin D (CyPD).

34 the conclusion that type 4 pili and the DNA translocator are distinct systems.

35 First, the pore-forming translocators are released.

36 rs through a distal needle 'tip complex' and translocators are secreted before effectors.

37 Unfolded translocators are secreted through the T3S needle prior

38 First, the translocators are secreted to form a pore in the host ce

39 n with AHR for dimerization with AHR nuclear translocator (ARNT) and binding to AHR-responsive enhanc

40 HIF1alpha)/aryl hydrocarbon receptor nuclear translocator (ARNT) and HIF2alpha/ARNT (HIF2) proteins i

41 ion of the aryl hydrocarbon receptor nuclear translocator (ARNT) as a CD30-interacting protein that m

42 on partner aryl hydrocarbon receptor nuclear translocator (ARNT) belong to the basic helix-loop-helix

43 rtner, the aryl hydrocarbon receptor nuclear translocator (ARNT) in the hematopoietic system to ablat

44 The aryl hydrocarbon receptor nuclear translocator (ARNT) is a basic helix-loop-helix Period/A

45 The aryl hydrocarbon receptor nuclear translocator (ARNT) is a promiscuous, basic helix-loop-h

46 ression of aryl hydrocarbon receptor nuclear translocator (ARNT) is critical during the development o

47 nd p57, we identify Aryl hydrocarbon nuclear translocator (Arnt) messenger RNA (mRNA) as a novel targ

48 ggest that aryl hydrocarbon receptor nuclear translocator (ARNT) plays an important role in the modul

49 Since dimerization with the AhR Nuclear Translocator (ARNT) protein, occurring through the Helix

50 heterodimerization partner, the AhR nuclear translocator (Arnt) protein.

51 The aryl hydrocarbon receptor nuclear translocator (ARNT) serves as the obligate heterodimeric

52 expressed aryl hydrocarbon receptor nuclear translocator (ARNT) subunit, which dimerize via basic he

53 factor that binds to the Ah receptor nuclear translocator (ARNT) to regulate the transcription of num

54 r (Hif)-1alpha, and aryl hydrocarbon nuclear translocator (Arnt) was generated.

55 the association of aryl hydrocarbon nuclear translocator (Arnt) with ligand-activated AhR.

56 (HIF-alpha.aryl hydrocarbon receptor nuclear translocator (ARNT)) requires association with several t

57 ', and the aryl hydrocarbon receptor nuclear translocator (ARNT), did not.

58 e with the aryl hydrocarbon receptor nuclear translocator (ARNT), to form functional transcription co

59 -helix Per-aryl hydrocarbon receptor nuclear translocator (ARNT)-Sim (bHLH-PAS) transcription factors

60 nt (XRE) in partnership with the AhR nuclear translocator (Arnt).

61 a subunit, aryl hydrocarbon receptor nuclear translocator (ARNT).

62 ha, HIF-2alpha, and aryl hydrocarbon nuclear translocator (ARNT).

63 AHRR(715), formed a complex with AHR nuclear translocator (ARNT).

64 -alpha and aryl hydrocarbon receptor nuclear translocator (ARNT, also known as HIF-beta) heterodimer

65 f the gene encoding aryl hydrocarbon nuclear translocator (ARNT, also known as HIF1beta) in the liver

66 ered an unexpected role of the mitochondrial translocator assembly and maintenance protein, Tam41, in

67 richia coli, SepL and SepD are essential for translocator but not effector protein export, but how th

68 ein called TpsA and a cognate outer membrane translocator called TpsB.

69 y functioning as a spacer to which cytosolic translocators can bind.

70 anism as a route to binding their far larger translocator cargo.

71 is renders SepL a high-affinity receptor for translocator/chaperone pairs, recognizing specific chape

72 Although all translocator chaperones dimerize, the location of the di

73 Given the crucial role of the translocator chaperones, we investigated the conformatio

74 Availability of metal transporters, translocators, chelators and the ability to express memb

75 omplexes caused the degradation of essential translocator components by the protease FtsH.

76 ing the functional interchangeability of the translocator components of the T3SA of Shigella, Salmone

77 e translocator and caused the degradation of translocator components, which may contribute to their e

78 pared with aryl hydrocarbon receptor nuclear translocator-deficient and wild type Hepa1c1c7 cells.

79 s AhR- and aryl hydrocarbon receptor nuclear translocator-deficient variants, benzo[a]pyrene-7,8-dion

80 The membrane-spanning ion translocator (DeltaehbF) and the large hydrogenase subun

81 ive secretion and thus pore formation of the translocators depend on their binding to and being trans

82 the plastidial phosphoenolpyruvate/phosphate translocator, displayed a trade off between seed size an

83 In a second, SepD-coupled step, translocators docked on SepL become secreted.

84 structural transition between the C-terminal translocator domain and the N-terminal passenger domain,

85 e periplasm support the possibility that the translocator domain must undergo extensive folding prior

86 rtion of the passenger domain and the entire translocator domain of DsrA exhibited binding to fibrone

87 structure of an extended version of the Hia translocator domain revealed the structural transition b

88 A SPATE polypeptide contains a C-terminal translocator domain that inserts into the bacterial oute

89 a signal sequence, a passenger domain, and a translocator domain.

90 s, the p73 passenger domain (PD) and the p82 translocator domain.

91 AipA and 76 aa in TaaP are homologous to the translocator domains of YadA from Yersinia enterocolitic

92 Dendrimeric polyguanidilyated translocators (DPTs) are nanosized novel dendrimers that

93 nt helicase activity, may also act as an RNA translocator during assembly of the primary replicase co

94 These novel export signals establish the translocator-effector secretion hierarchy, which in turn

95 an A/E pathogen by regulating mRNAs encoding translocators, effectors, or transcription factors.

96 in (ehbK and ehbL, respectively), and an ion translocator (ehbF).

97 serine protease EspP and the enterohemolysin translocator EhxD were found to be directly involved in

98 reduced pedestal formation, secretion of the translocators EspA, EspB, and EspD and the effector Tir

99 EE4 encodes a regulator of secretion (SepL), translocators (EspA, D and B), two chaperones (CesD2 and

100 important for substrate binding or targeting translocators for export.

101 How these translocators form a translocon in the lipid bilayer and

102 We have found that when added together, the translocators formed distinct hetero-complexes containin

103 studied, structural data on the hydrophobic translocators from the T3SS family remain elusive.

104 Previously, we showed that Sap translocator function is necessary for nontypeable Haemo

105 a subunit, aryl hydrocarbon receptor nuclear translocator (HIFbeta/Arnt).

106 ively controls the secretion of the putative translocator HrpK and the type III effector Eop1.

107 secrete the harpins HrpW1 and HopAK1 or the translocator HrpK1, suggesting that these proteins are r

108 med from two large membrane proteins called "translocators." Importantly, effective secretion and thu

109 ial steps of insertion and assembly of these translocators in the membrane.

110 proteins require protein machineries called translocators in the outer and inner membranes for impor

111 membrane pores by dilution of urea-denatured translocators in the presence of membranes.

112 In this work we characterize PopB, the major translocator, in both membrane-associated and PcrH-bound

113 support the hypothesis that the hydrophobic translocator (IpaB in Shigella) likely binds to a region

114 of a tip protein, IpaD, and two pore-forming translocators, IpaB and IpaC.

115 ch the heart-muscle-brain adenine nucleotide translocator isoform 1 (ANT1) was inactivated.

116 Down-regulation of AhR nuclear translocator levels using short interfering RNA in a hum

117 and muscle aryl hydrocarbon receptor nuclear translocator like 1 (BMAL1) and reducing its ubiquitylat

118 activators aryl hydrocarbon receptor nuclear translocator-like (Bmal1) alone, or circadian locomotor

119 activator aryl hydrocarbon receptor nuclear translocator-like (Bmal1) from smooth muscle, but not fr

120 hm-related aryl hydrocarbon receptor nuclear translocator-like 2 (Arntl2) gene has been identified as

121 and muscle aryl hydrocarbon receptor nuclear translocator-like protein (BMAL)-1 constitutes a major t

122 scle ARNT [aryl hydrocarbon receptor nuclear translocator]-like protein 1)-results in accelerated agi

123 The molecular identity of the MPD translocator (MPD flippase) is not known.

124 of MxiC regulation as follows: secretion of translocators, MxiC and/or effectors.

125 te/phosphate antiporter GPT1 as the putative translocator of Glc-6-phosphate for starch biosynthesis

126 -dependent anion channel (VDAC), the protein translocator of the outer membrane 40 (TOM40), or the fu

127 DNA translocators of natural transformation systems are comp

128 rium mutants as surrogates for expression of translocator orthologs identified from an extensive phyl

129 Further, the Sap translocator permease mediated heme transport into the b

130 induced the rapid agglomeration of the auxin translocators PIN2 and AUX1 and the brassinosteroid rece

131 Pseudomonas aeruginosa translocators PopB and PopD insert pores into membranes

132 rane pore formed by two T3S secreted protein translocators, PopB and PopD.

133 y into eukaryotic cells after assembly of a 'translocator' pore in the host plasma membrane.

134 The Class I mutant secretes translocators prematurely and is specifically defective

135 The PET radioligand (11)C-PBR28 targets translocator protein (18 kDa) (TSPO) and is a potential

136 As a PET biomarker for inflammation, translocator protein (18 kDa) (TSPO) can be measured wit

137 some BDZs also bind mitochondrial receptors [translocator protein (18 kDa) (TSPO)] and promote the sy

138 Translocator protein (18 kDa), known as TSPO, is a recog

139 Translocator protein (18 kDa, TSPO), previously known as

140 ectional design using (18)F-FDG (n = 43) and translocator protein (TSPO) ((18)F-GE180; n = 58) small-

141 e ((18)F-PBR06) for detecting alterations in translocator protein (TSPO) (18 kDa), a biomarker of mic

142 Translocator protein (TSPO) (18 kDa), a marker of inflam

143 Translocator protein (TSPO) (18 kDa), formerly called th

144 ivated, microglia increase the expression of translocator protein (TSPO) 18 kDa, thereby making the T

145 wth, inflammation, and invasion, such as the translocator protein (TSPO) and matrix metalloproteinase

146 In glioblastoma multiforme (GBM), translocator protein (TSPO) and murine double minute (MD

147 althy volunteers, genetically stratified for translocator protein (TSPO) binding status, underwent PE

148 es the first comprehensive quantification of translocator protein (TSPO) binding using SPECT and 6-ch

149 Ligands of the translocator protein (TSPO) elicit pleiotropic neuroprot

150 11C-PBR28 PET can detect the 18-kDa translocator protein (TSPO) expressed within macrophages

151 line class was exploited to search for a new translocator protein (TSPO) fluorescent probe endowed wi

152 et al. reported on a crystal structure for a translocator protein (TSPO) from Rhodobacter sphaeroides

153 adiolabeled ligands selective for the 18 kDa translocator protein (TSPO) has become the most widely u

154 The mitochondrial translocator protein (TSPO) has been implicated in CNS d

155 Elevated expression of translocator protein (TSPO) has been shown to predict di

156 ssion tomography (PET) imaging of the 18 kDa translocator protein (TSPO) has been used to investigate

157 PET radioligands targeting the 18-kDa translocator protein (TSPO) have been used as in vivo ma

158 ective of this study was to evaluate whether translocator protein (TSPO) imaging could be used to vis

159 Here we compare translocator protein (TSPO) imaging using 6-chloro-2-(4'

160 PET radioligand binding to the 18-kD translocator protein (TSPO) in the brains of patients wi

161 The translocator protein (TSPO) is a commonly used imaging t

162 Increased expression of translocator protein (TSPO) is a feature of microglial a

163 Translocator protein (TSPO) is a key member of the mitoc

164 Translocator protein (TSPO) is an 18-kDa cholesterol-bin

165 Translocator protein (TSPO) is expressed at a low level

166 Translocator protein (TSPO) is upregulated in activated

167 The 18-kDa mitochondrial translocator protein (TSPO) is upregulated in high-grade

168 in-3-yl)-N,N-die thylacetamide (6b), a novel translocator protein (TSPO) ligand exhibiting a 36-fold

169 4-phenylquinazoline-2-carboxamide series of translocator protein (TSPO) ligands have been explored f

170 It remains unclear how different translocator protein (TSPO) ligands reflect the spatial

171 ol-3-ylglyoxylamides as potent and selective translocator protein (TSPO) ligands, two subsets of nove

172 5 PET, which aims to image expression of the translocator protein (TSPO) on activated microglia in th

173 nificant role in Alzheimer disease (AD), and translocator protein (TSPO) PET imaging allows us to qua

174 -L-DOPA, 6-[(18)F]fluoro-m-tyrosine, and the translocator protein (TSPO) PET ligand [(18)F]DAA1106.

175 On the one hand, the translocator protein (TSPO) radioligand N,N-diethyl-2-(2

176 a-isosters of PK11195, the well-known 18 kDa translocator protein (TSPO) reference ligand, and synthe

177 se of SPECT/PET imaging agents targeting the translocator protein (TSPO) that is upregulated on activ

178 (11)C-PBR28 is a second-generation translocator protein (TSPO) tracer with characteristics

179 we investigated the involvement and role of translocator protein (TSPO), a biomarker of microglial a

180 For PET imaging of 18-kDa translocator protein (TSPO), a biomarker of neuroinflamm

181 Ligands of the 18 kDa translocator protein (TSPO), a marker for activated micr

182 on tomography (PET) and radioligands for the translocator protein (TSPO), a marker for glial activati

183 re the binding of [(11)C]PBR28 to the 18 kDa translocator protein (TSPO), a marker for microglial act

184 PBR28, we quantified expression of the 18kDa translocator protein (TSPO), a marker of activated micro

185 PBR28, we show increased brain levels of the translocator protein (TSPO), a marker of glial activatio

186 Brain levels of 18-kDa translocator protein (TSPO), a marker of microglial acti

187 eration tracer for PET imaging of the 18-kDa translocator protein (TSPO), a marker of neuroinflammati

188 Translocator protein (TSPO), also referred to as periphe

189 l with high affinity and selectivity for the translocator protein (TSPO), expressed on activated glia

190 Translocator protein (TSPO), previously known as the per

191 The 18-kilodalton translocator protein (TSPO), proposed to be a key player

192 Translocator protein (TSPO), which is upregulated in act

193 ivation can be detected in vivo using 18-kDa translocator protein (TSPO)-binding radioligands and PET

194 mography (PET) radioligands that bind to the translocator protein (TSPO).

195 oidogenic acute regulatory protein (StAR) or translocator protein (TSPO).

196 tive inflammatory processes by targeting the translocator protein (TSPO).

197 vated expression of the 18 kDa mitochondrial translocator protein (TSPO).

198 r developed for SPECT and targets the 18-kDa translocator protein (TSPO).

199 anied by a rapid up-regulation of the 18-kDa translocator protein (TSPO).

200 Function of the mammalian translocator protein (TSPO; previously known as the peri

201 ation is associated with increased levels of translocator protein 18 kDa (TSPO) and binding sites for

202 (PET) imaging with radiotracers that target translocator protein 18 kDa (TSPO) has become a popular

203 ssion tomography (PET) studies targeting the translocator protein 18 kDa (TSPO) have been limited by

204 In AD, the translocator protein 18 kDa (TSPO) is overexpressed in t

205 d can be monitored through expression of the translocator protein 18 kDa (TSPO) on activated microgli

206 ET imaging of brown adipose tissue (BAT) and translocator protein 18 kDa (TSPO) via a combination of

207 Translocator protein 18 kDa (TSPO), a biomarker of neuro

208 To measure translocator protein 18 kDa (TSPO), a marker of activate

209 ro evaluated for their potential to bind the translocator protein 18 kDa (TSPO), a protein today reco

210 ssion tomography with (11)C-PBR28 to measure translocator protein 18 kDa (TSPO), a putative biomarker

211 BR28 binds to the high-affinity state of the translocator protein 18 kDa (TSPO).

212 at is consistent with the biodistribution of translocator protein and yields a dose burden that is co

213 the healthy volunteers, suggesting increased translocator protein binding (z > 4.72).

214 n patients, and could explain the overlap in translocator protein binding values between patients wit

215 as to test for an association between 18 kDa translocator protein brain positron emission tomography

216 Translocator protein density increases when microglia ar

217 Translocator protein density measured by distribution vo

218 interaction between EspD and the hydrophilic translocator protein EspA.

219 Translocator protein genotyping allowed the classificati

220 fying the increased expression of the 18-kDa translocator protein have been developed.

221 The reduction of (11)C-PBR28 binding to translocator protein in the brain of patients with Parki

222 he recruitment and stable association of the translocator protein IpaB at the TTSA needle tip in the

223 tal sensor for triggering recruitment of the translocator protein IpaB to the needle tip.

224 GE180 for imaging activated microglia (18-kD translocator protein ligand [TSPO]) and static 30- to 60

225 ement, were examined using a specific 18-kDa translocator protein ligand, (11)C-PBR28, and T1-weighte

226 Translocator protein of 18 kDa (TSPO) is a highly conser

227 Glial activation in white matter assessed by translocator protein PET significantly improves predicti

228 Here we used the Pseudomonas aeruginosa translocator protein PopD as a model to identify its exp

229 progression using a second-generation 18-kDa translocator protein positron emission tomography radiot

230 sitron emission tomography scanning with the translocator protein radioligand 11C-PBR28 was performed

231 ivation in patients with MS using the 18-kDa translocator protein radioligand [(18)F]PBR111.

232 ata for the structure of the A139T mutant of translocator protein TSPO from Rhodobacter sphaeroides s

233 Translocator protein TSPO is an 18 kDa protein implicate

234 istribution volume of (11)C-PBR28 binding to translocator protein was significantly reduced compared

235 (PET) radiotracer [11C]PBR28, which binds to translocator protein, a molecular marker that is up-regu

236 trigger recruitment of the first hydrophobic translocator protein, IpaB, to the tip complex where it

237 YopD, a translocator protein, represses the expression of T3SS g

238 The 18 kDa translocator protein, TSPO, is a cholesterol-binding pro

239 f (11)C-PBR28 to the microglia marker 18 kDa translocator protein, was examined using positron emissi

240 11)C](R)PK11195-PET measures upregulation of translocator protein, which is associated with microglia

241 We found higher translocator protein-binding in slow decliners than fast

242 here when PET imaging was performed with the translocator protein-binding radioligand (18)F-GE180.

243 Amyloidosis controls displayed higher translocator protein-binding than controls, especially i

244 f interest and voxel-wise comparison, 18-kDa translocator protein-binding was higher in high affinity

245 Translocator protein-binding was measured using a simple

246 Translocator protein-binding was positively correlated w

247 We used translocator protein-targeted molecular imaging to obtai

248 Translocator protein-targeted PET is a reliable tool for

249 a specific PET ligand for the assessment of translocator protein.

250 de (DPA-714) is a radioligand for the 18-kDa translocator protein.

251 1 polymorphism in the gene encoding the 18Kd translocator protein.

252 whether microglial activity, measured using translocator-protein positron emission tomography (PET)

253 Translocator proteins (TSPOs) bind steroids and porphyri

254 cterial cells HrpJ controls the secretion of translocator proteins and inside plant cells it suppress

255 iple systems indicates that the pore-forming translocator proteins are exported before effectors, but

256 T3SS translocator proteins are required for effector proteins

257 These translocator proteins are stabilized in the cytoplasm an

258 e secretion channel because the pore-forming translocator proteins can still be secreted while effect

259 ovide new insights into interactions between translocator proteins critical for virulence.

260 N terminus of the type III secretion system translocator proteins EspB, EspD, and EspA mediate prote

261 es pilus protein and no longer secretes four translocator proteins in culture, and it fails to inject

262 Translocator proteins include two hydrophobic proteins,

263 eruginosa, the chaperone of the pore-forming translocator proteins is PcrH.

264 The translocator proteins PopB, PopD, and PcrV are secreted

265 pe III secretion systems rely on hydrophobic translocator proteins that form a pore in the host cell

266 To accomplish this, bacteria secrete translocator proteins that form a pore in the host-cell

267 The T3SS translocator proteins YopB and YopD form pores in host m

268 ecretion system, or with mutants lacking the translocator proteins, do not develop clinical disease,

269 Typhimurium chaperone and translocator proteins.

270 responded to oleic acid (OA) by using the FA translocator/receptor FAT/CD36 (CD36).

271 r secretion but that it is also required for translocator release.

272 complex with both type III secretion systems translocators, revealing that both molecules employ the

273 eased ADP-ATP exchange function and abnormal translocator reversal potential.

274 we reported on a novel structure of the DNA translocator secretin complex, PilQ, in Thermus thermoph

275 complete T3SS apparatus formation, a proper translocator secretion profile, and Shigella virulence.

276 ontact sensing with pilus length control and translocator secretion while also contributing to immuni

277 During translocator secretion, SepL/SepD suppress effector/chap

278 he basic helix-loop-helix/period AhR nuclear translocator single minded family.

279 ted in schizophrenia after controlling for a translocator-specific genetic polymorphism.

280 e transporter ABCB4 is a phosphatidylcholine translocator specifically expressed at the bile canalicu

281 The hydrophobic translocator subunits of this system, PopB and PopD, hav

282 gral pore, and the hydrophilic 'tip complex' translocator that connects the T3SS needle to the transl

283 for a separate nearby outer membrane protein translocator that serves as a pathway into target cells.

284 mily: a cytosolic chaperone, two hydrophobic translocators that form a plasma membrane-integral pore,

285 ict hierarchical manner, for example, first "translocators", then "effectors".

286 ly deregulated in triose phosphate/phosphate translocator (tpt) mutants.

287 of luminal proteins, the localization of the translocator varied during the cell cycle.

288 equired for insertion of the two hydrophobic translocators, VopB2 and VopD2, that constitute the memb

289 Unlike previously described hydrophilic translocators, VopW is itself translocated into the host

290 ng cells' resting potentials using other ion translocators, we show that a change in ectodermal volta

291 cell AHR levels, and the AHR and AHR nuclear translocator were required for optimal production of IL-

292 Translocators were purified as stable complexes with the

293 ependent anion channel or adenine nucleotide translocator, were reconstituted into lipid bilayers.

294 ly active heterodimer with ARNT (AHR nuclear translocator), which recognizes the dioxin response elem

295 vant chaperone proteins, and the AHR nuclear translocator, which heterodimerizes with the AHR to form

296 eral diffusion for binding sites on their OM translocators while bound to their primary OM receptor.

297 use the outer membrane porin, OmpF, as that translocator, while using a different primary receptor.

298 xport through the triose phosphate/phosphate translocator with subsequent MPK6 activation leading to

299 phagocytosis; furthermore, expression of the translocator YopB from intracellular bacteria also resul

300 ive for production of functional effector or translocator Yops indicated that translocation of cataly